Clinical Research Directory
Browse clinical research sites, groups, and studies.
Higher vs. Lower Dose Heparin for PCI
Sponsor: Population Health Research Institute
Summary
HD PCI is a multicenter, randomized, registry-based, cluster crossover design trial of higher dose versus lower dose heparin in patients undergoing elective percutaneous coronary intervention (PCI).
Official title: A Randomized Trial of Higher vs. Lower Dose Heparin for PCI
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
16000
Start Date
2022-03-02
Completion Date
2025-12
Last Updated
2025-07-31
Healthy Volunteers
No
Interventions
Higher Dose UFH
Centre wide policy of administering 100 U/kg bolus of intravenous UFH for elective PCI procedures
Lower Dose UFH
Centre wide policy of administering 70 U/kg bolus of intravenous UFH for elective PCI procedures
Locations (1)
Hamilton Health Sciences, General Hospital
Hamilton, Ontario, Canada